Skip to main content

Table 1 Demographic and laboratory data of the patient and control groups

From: The level of netrin-1 is decreased in newly diagnosed type 2 diabetes mellitus patients

Variables

T2DM (n = 30)

Control (n = 26)

P value

Gender (M/F)

16/14

13/13

 

Age (years)

52.7 (11.08)

52.96 (11.65)

0.932

Height (cm)

1.69 (0.89)

1.64 (0.87)

0.057

Weight (Kg)

66.13 (6.03)

65.92 (9.16)

0.920

PBG (mmol/L)

13.35 (11.40,15.23)

6.85 (6.10,7.20)

0.000

BMI (Kg/m2)

23.19 (2.41)

24.21 (2.58)

0.122

FBG (mmol/L)

8.50 (7.70,9.00)

5.14 (4.65,5.42)

0.000

HbA1c (%)

8.50 (7.90,9.10)

5.40 (5.30,5.85)

0.000

HDL-C (mmol/L)

1.22 (0.36)

1.20 (0.33)

0.860

LDL-C (mmol/L)

2.82 (2.04,3.73)

2.81 (1.84,3.73)

0.792

TC (mmol/L)

4.90 (0.79)

4.92 (0.88)

0.932

TG (mmol/L)

1.89 (1.05)

1.50 (0.36)

0.084

FINS (pmol/L)

20.39 (6.36)

16.72 (6.04)

0.032

PINS (pmol/L)

57.06 (2.48)

114.58 (32.58)

0.000

HOMA-IR

1.13 (0.39)

0.54 (0.20)

0.000

Netrin-1 (pg/mL)

0.96 ± 0.5

1.77 ± 1.18

0.001

  1. All parameters were expressed as mean ± SD (minimum–maximum) values unless otherwise stated. P < 0.05 was accepted as the level of significance
  2. FBG Fasting Blood Glucose, PBG Postprandial Blood Glucose, HbA 1c glycosylated hemoglobin, TG triglyceride, TC Total Cholesterol, HDL-C high density lipid-cholesterol, LDL-C low density lipid-cholesterol, FINS fasting insulin, PINS postprandial insulin, HOMA-IR homeostasis model assessment of insulin resistance